ARTICLE | Clinical News
Simponi golimumab regulatory update
October 4, 2010 7:00 AM UTC
Johnson & Johnson's Centocor Ortho Biotech Inc. subsidiary submitted an sBLA to FDA to expand the label for Simponi golimumab to include inhibiting the progression of structural damage, inducing major...